Skip to main content
. 2021 Dec 28;14(1):135. doi: 10.3390/cancers14010135

Figure A1.

Figure A1

Comparison between administration protocols obtained with different values of the parameter kAC. The dynamics refer to the ipilimumab mono-therapy as result of the optimization problem OP2, with Δt=3 weeks. Blue lines represent the model outcomes with the estimate value of kAC (the same presented in Figure 6, blue line), while orange lines represent the one with kAC2. The ipilimumab threshold has been highlighted with a black dotted line.